Avanos Medical, Inc. (AVNS.D)
- Sector
- Healthcare
- Industry
- Medical Devices
- Last price
- $24.99
- As of
Kresmion compiles this page from AVNS.D's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
AVANOS MEDICAL, INC. (AVNS.D): 4 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-07-30.
See the full AVNS.D dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for AVNS.D on one page. Preview it with sample data, then open it live with a free account.
Preview the AVNS.D dossierActive signals for AVNS.D
No recent signals on AVNS.D in the last 180 days.
FREE, NO ACCOUNT
Every signal on AVNS.D, as it fires
New filings, 13F moves and cross asset signals on AVNS.D land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in AVNS.D (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| MILLENNIUM MANAGEMENT LLCCUSIP 05350V106 · 2026Q2 | $37.9M | 0.01% | , |
| D. E. Shaw & Co., Inc.CUSIP 05350V106 · 2026Q2 | $7M | 0.00% | , |
| RENAISSANCE TECHNOLOGIES LLCCUSIP 05350V106 · 2026Q2 | $6.4M | 0.01% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 05350V106 · 2026Q2 | $1.2M | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, AVNS.D
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
AVNS.D against its peers
AVNS.D's operating margin of -8.8% ranks in the 64th percentile of 20 Medical Devices sub-industry peers, fiscal periods ending between 2025-12-28 and 2026-05-31.
| Metric | AVNS.D | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 701M USD | 218M USD | 79 | 20 |
| Gross margin | 50.5% | 64.4% | 28 | 19 |
| Operating margin | -8.8% | -17.5% | 64 | 20 |
| Net margin | -10.4% | -19.1% | 55 | 20 |
| Return on equity | -9.4% | -18.8% | 64 | 20 |
| P / E | n/a | 33.8x | n/a | 5 |
Peers (20): ENOV, AORT, BBNX, CBLL, QDEL, IART, SIBN, INMD, ESTA, BFLY, AXGN, UFPT, KIDS, NEOG, DCTH, SSII, TCMD, MASS, SENS, NPCE. Left out: LMRI (no annual filing), NHNKF (no annual filing), OSSUY (no annual filing), ALMR (no annual filing), BWAY (period gap). Fiscal periods ending between 2025-12-28 and 2026-05-31. Every figure is one full fiscal year read from one annual filing (AVNS.D: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow AVNS.D on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to AVNS.D for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.